• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Treatment for rheumatoid arthritis with immunogene therapy by angiostatin

Research Project

Project/Area Number 13670486
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 内科学一般
Research InstitutionUniversity of Occupational and Environmental Health

Principal Investigator

SAITO Kazuyoshi  University of Occupational and Environmental Health, School of Medicine, assistant professor, 医学部, 講師 (30279327)

Co-Investigator(Kenkyū-buntansha) TANAKA Yoshiya  University of Occupational and Environmental Health, School of Medicine, professor, 医学部, 教授 (30248562)
Project Period (FY) 2001 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥3,700,000 (Direct Cost: ¥3,700,000)
Fiscal Year 2003: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 2002: ¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 2001: ¥1,800,000 (Direct Cost: ¥1,800,000)
Keywordsrheumatoid arthritis / gene therapy / monoclonal antibody / angiostatin
Research Abstract

The aim of this research is establishment of antigen-specific immunogene therapy for rheumatoid arthritis with angiostatin. At first, we combined IL-10 expression vector and monoclonal antibodies against human ICAM-1 using sulfo-succinimidyl 4-(N-maleimidomethyl) cyclohexane-1-carboxylate (sulfo-SMCC). Then we added the conjugates to ICAM-1 expressing cells (ICAM-1 COS ; COS cells stably trasfected with ICAM-1 expression vector, synovial fibroblast cell line E11). We detected significant IL-10 in the supernatant of ICAM-1 expressing cells but not in control COS cells after 72hour incubation with immunogene. The tranfection efficiency increased four times when the expression vector was conjugated to Fab fragment of antibody. The addition of native antibody to the medium reduced transfection efficiency, supporting antigen-specific gene delivery of this method. We are planning to conjugate angiostatin gene and ICAM-1 monoclonal antibody and infuse to RA SCID mice (SCID mice transplanted with human synovial tissue)

Report

(4 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • 2001 Annual Research Report
  • Research Products

    (9 results)

All Other

All Publications (9 results)

  • [Publications] Nakayamada, S.: "β1 integrin-mediated signaling induces intercellular adhesion molecule 1 and Fas on rheumatoid synovial cells and Fas-mediated apoptosis"Arthritis and Rheum.. 48:(5). 1239-1248 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nakayamada, S.: "β1 Integrin/Focal Adhesion Kinase-mediated Signaling Induces Intercellular Adhesion Moledule 1 and Receptor Activator of Nuclear Factor κB Ligand on Osteoblasts and Osteoclast Maturation"JBC. 278:(46). 45368-45374 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Saito, K.: "Succeessfurl treatment with anti-CD20 monoclonal antibody (rituximab) of life-threatening refratory systemic lupus erythematosus with renal and central nervous system involvement"LUPUS. 12. 798-800 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nakayamada, S. et al.: "β1 integrin-mediated signaling induces intercellular adhesion molecule 1 and Fas on rheumatoid synovial cells and Fas-mediated apoptosis"Arthritis and Rheum.. 48:(5). 1239-1248 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nakayamada, S. et al.: "β Integrin/Focal Adhesion Kinase-mediated Signaling Induces Intercellular Adhesion Molecule 1 and Receptor Activator of Nuclear Factor κB Ligand on Osteoblasts and Osteoclast Maturation"JBC. 278(46). 45368-45374 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Saito, K. et al.: "Successful treatment with anti-CD20 monoclonal antibody (rituximab) of life-threatening refractory systemic lupus erythematosus with renal and central nervous system involvement"Lupus. 12. 798-800 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nakayamada, S.: "β1 integrin-mediated signaling induces intercellular adhesion molecule 1 and Fas on rheumatoid synovial cells and Fas-mediated apoptosis"Arthritis and Rheum.. 48(5). 1239-1248 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Nakayamada, S.: "β1 Integrin/Focal Adhesion Kinase-mediated Signaling Induces Intercellular Adhesion Moledule 1 and Receptor Activator of Nuclear Factor κB Ligand on Osteoblasts and Osteoclast Maturation"JBC. 278(46). 45368-45374 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Saito, K.: "Successful treatment with anti-CD20 monoclonal antibody (rituximab) of life-threatening refratory systemic lupus erythematosus with renal and central nervous system involvement"LUPUS. 12. 798-800 (2003)

    • Related Report
      2003 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi